Follow the people · Insider
Noah Goodman
Noah Goodman files insider transactions with the SEC as a chief business officer of Kymera Therapeutics (KYMR). We hold 6 disclosed purchases and sales filed since 9 April 2025, 3 of them in the last 90 days.
- Files forKYMR
- Disclosed buys and sells6 in all, 3 in the last 90 days
- Last disclosure2 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 April 2025 — 1 July 2026Chief Business Officer · Kymera Therapeutics (KYMR)21 Form 4 lines · source: SEC Form 4
Everything they disclosed
21 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,389 shares of Kymera TherapeuticsSEC Form 42 July 2026Common Stock · traded 1 July 2026 · filed 2 July 2026
- exercised options over 5,000 shares of Kymera TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- ▼ sold on the open market 2,500 shares of Kymera TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- ▼ sold on the open market 2,500 shares of Kymera TherapeuticsSEC Form 425 June 2026Common Stock · traded 25 June 2026 · filed 25 June 2026
- exercised options over 5,000 shares of Kymera Therapeutics (a derivative holding)SEC Form 425 June 2026Stock Option (Right to Buy) · traded 25 June 2026 · filed 25 June 2026
- exercised options over 2,500 shares of Kymera TherapeuticsSEC Form 422 June 2026Common Stock · traded 22 June 2026 · filed 22 June 2026
- ▼ sold on the open market 2,500 shares of Kymera TherapeuticsSEC Form 422 June 2026Common Stock · traded 22 June 2026 · filed 22 June 2026
- exercised options over 2,500 shares of Kymera Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 22 June 2026 · filed 22 June 2026
- ▼ sold on the open market 1,347 shares of Kymera TherapeuticsSEC Form 416 April 2026Common Stock · traded 14 April 2026 · filed 16 April 2026
- exercised options over 2,500 shares of Kymera TherapeuticsSEC Form 410 April 2026Common Stock · traded 9 April 2026 · filed 10 April 2026
- ▼ sold on the open market 3,094 shares of Kymera TherapeuticsSEC Form 410 April 2026Common Stock · traded 9 April 2026 · filed 10 April 2026
- ▼ sold on the open market 2,670 shares of Kymera TherapeuticsSEC Form 410 April 2026Common Stock · traded 9 April 2026 · filed 10 April 2026
- ▼ sold on the open market 2,500 shares of Kymera TherapeuticsSEC Form 410 April 2026Common Stock · traded 9 April 2026 · filed 10 April 2026
- ▼ sold on the open market 2,000 shares of Kymera TherapeuticsSEC Form 410 April 2026Common Stock · traded 10 April 2026 · filed 10 April 2026
- exercised options over 2,500 shares of Kymera Therapeutics (a derivative holding)SEC Form 410 April 2026Stock Option (Right to Buy) · traded 9 April 2026 · filed 10 April 2026
- was granted 9,225 shares of Kymera TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 18,450 shares of Kymera Therapeutics (a derivative holding)SEC Form 44 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 4 March 2026
- was granted 18,450 shares of Kymera Therapeutics (a derivative holding)SEC Form 44 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 4 March 2026
- was granted 9,225 shares of Kymera TherapeuticsSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 100,000 shares of Kymera Therapeutics (a derivative holding)SEC Form 49 April 2025Stock Option (Right to Buy) · traded 8 April 2025 · filed 9 April 2025
- was granted 50,000 shares of Kymera TherapeuticsSEC Form 49 April 2025Common Stock · traded 8 April 2025 · filed 9 April 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.